RKDA
Income statement / Annual
Last year (2023), Arcadia Biosciences, Inc.'s total revenue was $5.33 M,
a decrease of 46.46% from the previous year.
In 2023, Arcadia Biosciences, Inc.'s net income was -$13.98 M.
See Arcadia Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$5.33 M
|
$9.96 M
|
$6.78 M
|
$8.03 M
|
$1.17 M
|
$1.46 M
|
$4.03 M
|
$3.19 M
|
$5.41 M
|
$6.98 M
|
Cost of Revenue |
$3.30 M |
$9.80 M |
$8.71 M |
$5.20 M |
$885,000.00 |
$661,000.00 |
$283,000.00 |
$895,000.00 |
$892,000.00 |
$2.00 M |
Gross Profit |
$2.03 M |
$154,000.00 |
-$1.93 M |
$2.84 M |
$284,000.00 |
$803,000.00 |
$3.74 M |
$2.29 M |
$4.52 M |
$4.99 M |
Gross Profit Ratio |
0.38 |
0.02 |
-0.28 |
0.35 |
0.24 |
0.55 |
0.93 |
0.72 |
0.84 |
0.71 |
Research and Development
Expenses |
$1.39 M
|
$1.51 M
|
$3.89 M
|
$7.96 M
|
$7.10 M
|
$6.07 M
|
$7.41 M
|
$8.66 M
|
$8.97 M
|
$10.01 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$16.47 M
|
$13.57 M
|
$11.60 M
|
$10.65 M
|
$12.25 M
|
$11.12 M
|
$10.13 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$14.51 M
|
$18.05 M
|
$22.94 M
|
$16.47 M
|
$13.57 M
|
$11.60 M
|
$10.65 M
|
$12.25 M
|
$11.12 M
|
$10.13 M
|
Other Expenses |
$73,000.00 |
$33,000.00 |
$10.11 M |
$105,000.00 |
$466,000.00 |
-$3.61 M |
$281,000.00 |
$340,000.00 |
$521,000.00 |
$0.00 |
Operating Expenses |
$15.97 M |
$19.56 M |
$26.83 M |
$24.43 M |
$20.67 M |
$17.67 M |
$18.06 M |
$20.91 M |
$20.09 M |
$20.14 M |
Cost And Expenses |
$19.27 M |
$29.36 M |
$35.54 M |
$29.63 M |
$21.55 M |
$18.33 M |
$18.34 M |
$21.81 M |
$20.98 M |
$22.14 M |
Interest Income |
$695,000.00 |
$289,000.00 |
$20,000.00 |
$47,000.00 |
$5,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$0.00 |
$289,000.00 |
$20,000.00 |
$47,000.00 |
$5,000.00 |
$0.00 |
$747,000.00 |
$1.32 M |
$2.66 M |
$1.39 M |
Depreciation &
Amortization |
$287,000.00
|
$1.36 M
|
$1.04 M
|
$662,000.00
|
$194,000.00
|
$154,000.00
|
$279,000.00
|
$304,000.00
|
$294,000.00
|
$358,000.00
|
EBITDA |
-$13.94 M
|
-$13.65 M
|
-$23.27 M
|
-$5.44 M
|
-$28.67 M
|
-$13.32 M
|
-$14.66 M
|
-$17.98 M
|
-$14.98 M
|
-$15.39 M
|
EBITDA Ratio |
-2.62 |
-2.28 |
-2.71 |
-2.59 |
-17.48 |
-15.63 |
-3.42 |
-5.64 |
-2.72 |
-2.12 |
Operating Income Ratio
|
-2.62
|
-1.95
|
-5.24
|
-2.69
|
-17.43
|
-11.52
|
-3.56
|
-5.84
|
-2.87
|
-2.17
|
Total Other
Income/Expenses Net |
$781,000.00
|
$3.19 M
|
$19.39 M
|
$6.63 M
|
-$9.49 M
|
$3.40 M
|
-$1.37 M
|
-$979,000.00
|
-$2.37 M
|
-$1.99 M
|
Income Before Tax |
-$13.16 M |
-$15.60 M |
-$16.13 M |
-$6.15 M |
-$28.87 M |
-$13.47 M |
-$15.68 M |
-$19.60 M |
-$17.93 M |
-$17.14 M |
Income Before Tax Ratio
|
-2.47
|
-1.57
|
-2.38
|
-0.77
|
-24.7
|
-9.2
|
-3.89
|
-6.15
|
-3.31
|
-2.46
|
Income Tax Expense |
$8,000.00 |
$14,000.00 |
$2,000.00 |
-$124,000.00 |
$2,000.00 |
$10,000.00 |
$26,000.00 |
$25,000.00 |
$26,000.00 |
$263,000.00 |
Net Income |
-$13.98 M |
-$15.61 M |
-$16.13 M |
-$6.03 M |
-$28.87 M |
-$13.48 M |
-$15.71 M |
-$19.62 M |
-$17.96 M |
-$18.34 M |
Net Income Ratio |
-2.62 |
-1.57 |
-2.38 |
-0.75 |
-24.7 |
-9.21 |
-3.9 |
-6.16 |
-3.32 |
-2.63 |
EPS |
-11.3 |
-26.05 |
-30.33 |
-24.2 |
-181.5 |
-143.16 |
-291.38 |
-353.85 |
-503 |
-448.39 |
EPS Diluted |
-11.3 |
-26.05 |
-30.33 |
-24.2 |
-181.5 |
-143.16 |
-291.38 |
-353.85 |
-503 |
-448.39 |
Weighted Average Shares
Out |
$1.24 M
|
$599,389.00
|
$532,015.00
|
$248,975.00
|
$159,077.00
|
$94,160.00
|
$53,905.00
|
$55,458.00
|
$35,698.00
|
$40,900.00
|
Weighted Average Shares
Out Diluted |
$1.24 M
|
$599,389.00
|
$532,015.00
|
$248,975.00
|
$159,077.00
|
$94,160.00
|
$53,905.00
|
$55,458.00
|
$35,698.00
|
$40,900.00
|
Link |
|
|
|
|
|
|
|
|
|
|